Article


Nature Structural & Molecular Biology 15, 50 - 56 (2008)
Published online: 16 December 2007 | doi:10.1038/nsmb1350

Structural basis for synaptic adhesion mediated by neuroligin-neurexin interactions

Xiaoyan Chen1, Heli Liu1, Ann H R Shim1, Pamela J Focia1 & Xiaolin He1


The heterophilic synaptic adhesion molecules neuroligins and neurexins are essential for establishing and maintaining neuronal circuits by modulating the formation and maturation of synapses. The neuroligin-neurexin adhesion is Ca2+-dependent and regulated by alternative splicing. We report a structure of the complex at a resolution of 2.4 Å between the mouse neuroligin-1 (NL1) cholinesterase-like domain and the mouse neurexin-1beta (NX1beta) LNS (laminin, neurexin and sex hormone–binding globulin–like) domain. The structure revealed a delicate neuroligin-neurexin assembly mediated by a hydrophilic, Ca2+-mediated and solvent-supplemented interface, rendering it capable of being modulated by alternative splicing and other regulatory factors. Thermodynamic data supported a mechanism wherein splicing site B of NL1 acts by modulating a salt bridge at the edge of the NL1-NX1beta interface. Mapping neuroligin mutations implicated in autism indicated that most such mutations are structurally destabilizing, supporting deficient neuroligin biosynthesis and processing as a common cause for this brain disorder.


The development of the central nervous system relies on specific cell-cell recognition and communication through synapses, the specialized junctions between neurons. At the synapse, presynaptic and postsynaptic membranes are linked together by a variety of adhesion molecules1. Two adhesion molecules that have been implicated in the establishment and maturation of synaptic contacts are neuroligins, which are postsynaptic proteins, and neurexins, which are presynaptic proteins2, 3, 4, 5, 6, 7. Polymorphisms in neuroligin and neurexin genes have been associated with several cases of cognitive disorders such as autism and mental retardation8, 9, 10, 11, 12, 13, 14, 15.

Neuroligins are a family of four type I transmembrane proteins (neuroligins 1–4, or NL1–NL4), whose extracellular segments contain a globular domain homologous to acetylcholinesterase (AChE) and a stalk rich in O-linked carbohydrates16. The neurexin family consists of three genes, each generating a long mRNA encoding alpha-neurexin and a short mRNA encoding beta-neurexin. The extracellular segment of alpha-neurexins contains six LNS domains, whereas beta-neurexins contain a single LNS domain identical to the last one of alpha-neurexins. The cholinesterase-like domain (CLD) of neuroligins and the LNS domain common between alpha- and beta-neurexins are implicated in recognition4, 17. The structure of the NX1beta LNS domain has been determined18. The structure of neuroligins, and the overall arrangement of neuroligin and neurexin within the synapse, have been extensively studied by hydrodynamic and small-angle scattering methods19, 20, 21. Neuroligin-neurexin binding is Ca2+-dependent22, but the exact position of the Ca2+ binding site and the role of Ca2+ binding in neuroligin-neurexin association have remained uncertain.

Both neuroligins and neurexins undergo extensive alternative mRNA splicing16. The CLD of neuroligins contains splice site A and, specifically in NL1, an additional splice site B. alpha-neurexins contain five splice sites, in which the fourth site (SS 4) is located in the common LNS domain of alpha- and beta-neurexins. Both neuroligin splice sites and neurexin SS 4 have been shown to modulate synaptic recognition20, 23, 24, 25, 26, 27. Previous small-angle scattering data21 suggested that these splice sites are central or proximal to neuroligin-neurexin interaction, but their exact positions relative to the neuroligin-neurexin interface, as well as the mechanism by which these sites modulate neuroligin-neurexin recognition, remained unclear. Here we report a crystal structure at 2.4-Å resolution of the complex between the CLD of mouse NL1 and the LNS domain of mouse NX1beta, revealing the basis of neuroligin-neurexin recognition and illuminating the mechanisms of regulation by factors such as Ca2+ and alternative splicing.

Top

Results

Confirmation of the functional unit of the NL1–NX1beta complex

To reconstitute the NL1–NX1beta complex, we expressed the NX1beta LNS domain and the NL1 CLD using baculovirus. Crystals of the complex were obtained with NL1 and NX1beta combined in the presence of Ca2+. The structure was determined by molecular replacement. The asymmetric unit contained two NX1beta and two NL1 molecules. Because each NL1 was involved in crystal packing with four neighboring NX1beta molecules, it was unclear which pairs of NL1 and NX1beta are the functional units. The interaction between neuroligins and neurexins has not been systematically mapped, despite existing mutagenesis data on both NL1 and NX1beta20, 25. To prevent the misidentification of packing artifacts as functional interfaces, we studied all four NL1-NX1beta crystal contacts, which bury surface areas of 1,160 Å2, 1,030 Å2, 560 Å2 and 140 Å2, respectively (Fig. 1 and Supplementary Fig. 1 online). We tested the two larger interfaces (1 and 2) by designing five NX1beta mutants (S107R, L135R, D137S, I236R and N238R) within interface 1 and two NX1beta mutants (R112E and T179A) within interface 2, and we compared the NL1-binding capacities of the mutants and wild-type NX1beta. His-tag pull-down experiments (Fig. 1a) indicated that only the interface-1 mutations reduced NL1 binding. To further evaluate the importance of interface 1, we tested mutations (E397A and N400A) of two NL1 residues central to interface 1 and involved in many NL1-NX1beta interactions. These NL1 mutants did not show detectable binding to wild-type NX1beta in calorimetric experiments (Supplementary Fig. 2 online). The mutagenesis data therefore indicated that interface 1 (see the buried interfaces in Fig. 1) was physiologically relevant.

Figure 1: Structure of the NL1–NX1bold beta complex.

Figure 1 : Structure of the NL1|[ndash]|NX1|[beta]| complex.

(a) His-tag pull-down assay showing effects of mutagenesis of NX1beta surface residues on NL1 binding. Left, Coomassie-stained SDS-PAGE gel, with upper bands being His-tagged NL1 attached to Ni-NTA resin, and lower bands being non-His-tagged NX1beta mutants retained by NL1. Lane assignments are indicated in the corresponding table (right), along with the NL1-binding capacities of the mutants compared with the wild type. (b) The 2:2 NL1–NX1beta complex in a ribbon model, viewed from the NX1beta membrane. NL1, orange and pink; NX1beta, blue and cyan; Ca2+ ions, red balls. (c) The complex viewed from the side.

Full size image (96 KB)

Structure of the NL1–NX1beta complex

The NL1–NX1beta complex contained a central NL1 dimer and two NX1beta monomers, one attached to each side (Fig. 1b,c). NL1 dimerization ensures NX1beta clustering. The NL1 monomer contained a 550–amino acid, globularly shaped CLD, with a central 11-strand beta-sheet flanked by alpha-helices. The NL1 dimer in the complex, as expected from its approx30% sequence identity to AChE28, could be superimposed upon the mouse AChE dimer (r.m.s. deviation 1.4 Å for Calpha atoms) (Supplementary Fig. 3 online). The dimer interface of NL1, as in AChE, was formed by four alpha-helices near the C termini, with two helices (residues 450–460 and 620–635) from each monomer. The dimer interface was large, burying 1,590 Å2 of surface area, and was primarily hydrophobic. With the Met459-Met459 and Leu633-Leu633 contacts from both chains as the dividing line, the interface appeared as a duplex of two equivalent subinterfaces. Each subinterface was marked by a central Phe458 surrounded by Trp463 and Met459 from its own monomer and Met459, Leu625 and Leu629 from the opposing monomer (Supplementary Fig. 3). The NX1beta LNS domain was beta-sandwich-like, as described18. Each NX1beta used a loop-rich surface lying on the side of the beta-sandwich, previously designated as the 'hypervariable surface'18, to contact NL1, whereas NL1 used the region around the exposed side of the central beta-sheet to contact NX1beta. With respect to the orientation of NX1beta relative to NL1, the beta-sheets of NX1beta and the long axis of NL1 dimer were vertical, but not, as suggested in previous small-angle scattering studies21, parallel to each other.

The Ca2+ binding site is in NX1beta but also relies on NL1

After refining the protein part of the structure, we searched the asymmetric unit for Ca2+. Initially, our effort was compromised by the requirement for sodium citrate, a known chelating reagent, at high concentration (approx1 M) for crystallization. Nevertheless, the SIGMA-weighted composite omit 2FoFc map and the protein-only FoFc electron density map (Supplementary Fig. 4 online) showed a unique site in each pair of NL1 and NX1beta, surrounded by four NX1beta oxygen atoms. The electron density for the site was modest. We speculated that it might be a Ca2+ ion present at partial occupancy. Although the total Ca2+ concentration was 10 mM during crystallization, free Ca2+ was estimated to be only approx10- 2 mM because of citrate chelation. We therefore speculated that citrate chelation competed with the Ca2+ binding site, resulting in the low occupancy. To verify our speculations, we replaced citrate with acetate in the mother liquor before measuring X-ray diffraction data and obtained a data set at a resolution of 3.5 Å. After simple rigid-body refinement to accommodate cell-dimension differences, we calculated electron density maps using the data from the acetate-adapted crystal. Strong electron density at this position unambiguously indicated that it was a Ca2+ binding site (Fig. 2a and Supplementary Fig. 4).

Figure 2: The Ca2+ binding site in the NL1-NX1bold beta complex.

Figure 2 : The Ca2+ binding site in the NL1-NX1|[beta]| complex.

(a) Coordination of the Ca2+ and its effect on NL1-NX1beta interaction. NX1beta, cyan; NL1, pink. Ca2+ and water molecules, large and small red balls, respectively. Hydrogen bonds and Ca2+-oxygen interactions, dashed red lines. FoFc electron density calculated with the Ca2+ and water molecules omitted from the model is shown contoured at 4.5sigma. The Ca2+ ion is octahedrally coordinated by four protein oxygen atoms from NX1beta and two water molecules. WAT1 is bonded to both the Ca2+ and two NL1 oxygen atoms. The NX1beta Asn238 side chain is bound to both the Ca2+ and the NL1 main chain. (b) Overlaying the structures of the Ca2+ bound to NX1beta (Ca2+, red ball; NX1beta, cyan sticks) with the Ca2+ bound to NX1alpha-LNS2 (both Ca2+ and NX1alpha colored orange) shows that the Ca2+ binding sites are in similar positions with respect to the LNS domain. The main difference is that the positioning of WAT1 in NX1beta requires NL1, but the equivalent water in the NX1alpha-LNS2 structure can be positioned by the side chain of Tyr412.

Full size image (62 KB)

The bound Ca2+ had direct contacts only with NX1beta, and not with NL1 as suggested elsewhere22. The Ca2+ binding site in NX1beta was located at the hypervariable surface. Coordination of the bound Ca2+ was consistent with an octahedral geometry (n = 6) (Fig. 2a), with two main chain carbonyl oxygen atoms (Val154 and Ile236), two side chain oxygen atoms (Asp137 and Asn238) from NX1beta, and two water molecules ligated to the Ca2+. Although NX1beta provided all the non-solvent oxygen atoms for the bound Ca2+, we did not detect binding between Ca2+ and NX1beta in the absence of NL1 using calorimetry (Supplementary Fig. 5 online), consistent with previous observations that Ca2+ incubation does not induce structural change of NX1beta22. Thus, Ca2+ binding seems to require the presence of NL1. In the NL1–NX1beta structure, one of the water molecules in Ca2+ coordination, WAT1, was hydrogen bonded to the main chain carbonyl of Gln395 and the side chain carboxyl of Glu397 from NL1, suggesting that NL1 acts in Ca2+ binding by coordinating this water molecule for the completion of the Ca2+ binding site.

Superimposition of the structure of NX1beta in our complex with the structure of NX1alpha-LNS2 (ref. 29) showed that their Ca2+ ions were bound at similar positions (Fig. 2b). Most structural elements for Ca2+ coordination were conserved, except that one water molecule in NX1alpha-LNS2 was replaced with the amide carbonyl from NX1beta Asn238. Because the NX1alpha-LNS2 Ca2+ binding site includes more water molecules, we find it surprising that NX1alpha-LNS2 alone binds Ca2+ at measurable affinity (approx400 muM)29, but NX1beta alone does not show detectable Ca2+ binding. One explanation may be the differences in the positionings of these water molecules, especially the one at the NX1beta WAT1 position (Fig. 2b).

The interface between NL1 and NX1beta

The NL1-NX1beta interface contained a protruding surface patch at the edge of central beta-sheet of NL1 and part of the hypervariable surface of NX1beta (Fig. 3). The majority of the interface on the NL1 side emanated from loop 395–402, a smaller fraction from the short, flanking loop 499–502 and a minor fraction from side chains extending from loop 292–310 and loop 380–388. The NX1beta side of the interface consisted of two long, parallel loops (101–110 and 231–241) and a short loop (131–137). The 1,160-Å2 total buried solvent-accessible surface area between each pair of NX1beta and NL1 molecules was smaller than the average of 1,600 plusminus 400 Å2 expected for protein-protein interfaces30. The interface was primarily composed of hydrophilic residues. The only interactions between hydrophobic residues were between NX1beta Leu135 and NL1 Phe499 and between NX1beta Ile236 and NL1 Leu399. A total of six direct hydrogen bonds were formed between NL1 and NX1beta, mostly contributed by only two residues, Glu397 and Asn400, from NL1 (Fig. 3). Mutation of either residue to alanine (E397A or N400A) abolished NL1-NX1beta binding, confirming their essential roles (Supplementary Fig. 2). At the edge of the interface, two salt bridges were formed, between NL1 Asp387 and NX1beta Arg232 and between NL1 Glu297 and NX1beta Arg109. Notably, these two salt bridges were not grouped with other interactions and therefore are not reinforced by the adjacent structural elements. Water molecules filled in the unoccupied space between the opposing surfaces of NX1beta and NL1, with some forming hydrogen bonds with both molecules. The hydrophilic and water-supplemented nature of the NL1-NX1beta interface is consistent with previous studies showing that NL1-NX1beta binding affinity is inversely related to the ionic strength of the solution19.

Figure 3: The NL1-NX1bold beta interface.

Figure 3 : The NL1-NX1|[beta]| interface.

(a) Side view. NL1 and NX1beta backbones are shown as coils. The side chains of the important residues in the NL1-NX1beta interaction are shown as sticks. Water molecules and Ca2+, red balls. NX1beta splice site 4 (cyan square) lies near the salt bridge between NL1 Asp387 and NX1beta Arg232. (b) View from the NL1 direction. NL1 splice site B, (pink square) lies near the salt bridge between NL1 Glu297 and NX1beta Arg109.

Full size image (58 KB)

Specificity of neuroligin-neurexin interactions

The ranking order of neuroligins toward binding NX1beta is NL1 > NL4 double greater than NL3 > NL2 (ref. 20). Sequence alignment of neuroligins showed that their central neurexin-binding loops (NL1 395–402) were identical (Supplementary Fig. 6 online), and the surrounding small loops bore differences. NL1 and NL4 differ only slightly (NL1 Tyr499 versus NL4 Phe463), explaining their close neurexin-binding affinities. The weaker NX1beta-binding affinity of NL3 can be attributed to the Tyr right arrow His substitution at the NL1 Tyr295 position, where a hydrophobic side chain is required for positioning the 294–297 loop for contacting NX1beta. NL2 differs markedly from other neuroligins by a glycine right arrow glutamine substitution (NL1 Gly500 versus NL2 Gln475). In the NL1–NX1beta complex, NL1 Gly500 faced the NX1beta surface closely and could not be substituted by any residue with a side chain, as the side chain would conflict with NX1beta Ser239. Hence, structural rearrangement would be required in NL2 to accommodate Gln475 when binding neurexins. This would be unfavorable, because the flanking residues interacted extensively with NX1beta in the complex. On the basis of our structure, therefore, NL2 is not an optimal ligand for neurexins.

Effects of splice sites on NL1-NX1beta interaction

Of the three alternative spice sites harbored in the complex, the site A and site B inserts of NL1 reduce NL1-NX1beta binding by two- to five-fold20, whereas the SS 4 insert in neurexins nearly blocks the neuroligin-neurexin association26, 27. Our structure indicated that site A of NL1 was more than 25 Å from the edge of the NL1-NX1beta interface, and it is therefore unlikely to interfere with the neuroligin-neurexin association (Fig. 4a). In comparison, site B of NL1 was only approx10 Å from the edge of the interface and so it is more likely to interfere with NL1-NX1beta binding.

Figure 4: Alternative splice sites in the NL1–NX1bold beta complex.

Figure 4 : Alternative splice sites in the NL1|[ndash]|NX1|[beta]| complex.

(a) The locations of the NL1 sites, A and B, and NX1beta SS 4 on the surface of the complex. Each residue immediately adjacent to the potential insert is colored green and shown in space-filling representation. (b) Calorimetric titration between NX1beta and NL1 without the site B insert. (c) Calorimetric titration between NX1beta and NL1 with the site B insert. The NL1 protein does not have the site A insert, and the NX1beta protein does not have the SS 4 insert.

Full size image (84 KB)

To determine how the site-B insert of NL1 produces its inhibitory effect, we used isothermal titration calorimetry to compare the thermodynamic profiles of NL1, with and without the site-B insert (NL1-DeltaA versus NL1-DeltaADeltaB), in binding to NX1beta (Fig. 4b,c). The measured affinities for NL1-DeltaA/NX1beta and NL1-DeltaADeltaB/NX1beta were 430 nM and 93 nM, respectively. Both binding events were enthalpy-driven and were entropically unfavorable. The DeltaH value of approximately - 20 kcal mol- 1 agreed with the number of salt bridges and hydrogen bonds in the complex. Comparing the two thermodynamic profiles showed that the site-B insert produced an enthalpic loss (DeltaH difference approx1.4 kcal mol- 1) but an entropic gain (TDeltaS difference approx0.5 kcal mol- 1). There are two possible ways that the site-B insert, which was near the NL1-NX1beta interface, could exert its negative influence on binding. One possibility is steric hindrance: bringing the two proteins together could limit the flexibility of the insert, resulting an entropic loss. Such a possibility does not agree with our thermodynamic data, which showed that the site-B insert brought an entropic gain. The other possibility is that the site B insert disturbs or weakens an existing hydrogen bond or salt bridge. This possibility is consistent with the thermodynamic data: the enthalpic loss would be due to bond breaking, and the associated entropic gain would be due to increased conformational flexibility.

Consistent with the second possibility, analyzing the NL1-NX1beta structure showed that the NL1 site-B insert could interfere with an adjacent, dynamic salt bridge between NL1 Glu297 and NX1beta Arg109. In the structure of the complex without the NL1 site-B insert, the NX1beta Arg109 side chain showed no electron density beyond Cbeta, indicating that it was flexible (Supplementary Fig. 7 online), but in its low-energy, extended conformation, both the Neta1 and Nepsilon atoms of NX1beta Arg109 were at appropriate distances from the carboxyl group of NL1 Glu297 to form a salt bridge. Neuroligin-neurexin interactions have been shown to be electrostatically driven19. Mutation of E297A (combined with a remote K306A mutation that is not likely to be relevant) reduces NL1 binding to NX1beta by five-fold20, supporting the existence of this salt bridge. Given the flexibility of NX1beta Arg109, the correct conformation and the availability of NL1 Glu297 become important for the energetics of this salt bridge. In NL1 without the site-B insert, Glu297 is held inflexible in a very tight turn; in NL1 with the site B insert (298–306), the insert, which is next to Glu297, would probably release this tight-turn conformation and result in increased flexibility of Glu297, thus destabilizing the salt bridge with NX1beta Arg109. The effect of replacing Glu297 with alanine in NL1 without insert B (ref. 20) is similar to that of adding insert B (Fig. 4); each reduces binding by about five-fold, further supporting the concept that insert B acts though modulating the NL1 Glu297–NX1beta salt bridge. Notably, the inhibitory effect of the NL1 site-B insert seems to be augmented by the presence of N-linked glycosylation in the middle of the insert residues23. This is perhaps because the N-linked glycan, with its large size, can restrain the conformation of the insert and adjacent residues, including Glu297, decreasing the possibility that NL1 Glu297 will achieve the conformation that allows salt bridge formation with NX1beta Arg109.

Analysis of the structural elements around NX1beta SS 4 indicated that the SS 4 insert may use a similar mechanism to that of the NL1 site-B insert to modulate NL1-neurexin recognition. This insert site is distant from the main NL1-NX1beta binding interface, and is unlikely to act through steric hindrance. However, it is immediately adjacent to NX1beta Arg232, which forms a salt bridge with NL1 Asp387 in the complex (Fig. 3). An insertion of 30 amino acids between Ala200 and Gly231 is likely to alter the conformation of NX1beta Arg232, resulting in the loss or weakening of this salt bridge. Because incorporating the SS-4 insert reduces NL1-NX1beta binding to an undetectable value, direct thermodynamic evidence is unavailable for this supposition.

Effects of the autism-related neuroligin mutations

Aberrant neuroligin genes have been linked to autism11, 15, 16, 31, but it remains unclear how the point mutations of neuroligins are related to the genesis of the disease. An NL3 mutation (R451C) and three NL4 mutations (G99S, K378R and V403M), located in the CLD domain, have been found in autistic subjects11, 15. These residues, corresponding to Arg473, Asp106, Lys414 and Val439 of NL1, respectively, are highly conserved, except for NL1 Asp106 (Supplementary Fig. 6). An inspection of the locations of these residues in the NL1–NX1beta complex indicated that they were distant from the neuroligin-neurexin interface and the neuroligin dimer interface, and so are unlikely to affect neuroligin-neurexin binding or neuroligin dimerization (Fig. 5). All but Asp106 were largely buried beneath the protein surface in NL1. This was unexpected, in that most of these residues—in particular, Lys414 and Arg473—are large hydrophilic residues. Their buried nature indicates that most of the autism mutations in neuroligins compromise structural integrity. The mutations most likely result in insufficient folding, secretion or viability of the specific types of neuroligins, which would alter their functions at the synapse.

Figure 5: Autism-related neuroligin point mutations.

Figure 5 : Autism-related neuroligin point mutations.

The mutated residues, NL1 Asp106 (corresponding to the NL4 G99S mutation), NL1 Lys414 (corresponding to the NL4 K378R mutation), NL1 Arg473 (corresponding to the NL3 R451C mutation) and NL1 Val439 (corresponding to the NL4 V403M mutation), are colored green and shown in space-filling representation, and are mapped on the NL1–NX1beta complex (ribbons). These residues are away from the binding and dimerization interfaces, and are mostly buried.

Full size image (71 KB)

Top

Discussion

In this article we determined the structure of the complex between the NL1 CLD and the NX1beta LNS domain. We found that the neuroligin-neurexin association was highly hydrophilic, Ca2+-mediated and water-supplemented, allowing it to be easily affected by a variety of influences such as ionic strength, Ca2+ concentration, amino acid substitution and proximal splice inserts.

With respect to Ca2+, the unexpected Ca2+ binding site in NX1beta but not in NL1 is consistent with recent mutagenesis studies showing that mutations of NX1beta residues disrupt Ca2+-dependent postsynaptic protein clustering and neuroligin binding25. It is also consistent with the identification of a Ca2+ binding site in the second LNS domain of NX1alpha29, supporting the LNS domain as a common Ca2+ binding module.

With respect to alternative splicing, such a process is widely used to generate molecular diversity for receptor-ligand recognition, and the mechanisms by which splicing modulates recognition are only beginning to emerge. A recent study showed that Drosophila melanogaster Dscam, a protein implicated in neural wiring, uses splice variant–specific sequences to form homophilic interactions32, unlike neurexins and neuroligins, in which splice sites seem to interfere indirectly, from outside the binding interface. This fundamental difference is based on different natures of the splicing: the splicing of Dscam generates mutually exclusive but interchangeable regions that are essential parts of the structure, whereas the splicing of neuroligins and neurexins generates inserts or deletions that are not essential to structural integrity. It has been estimated that 60% of the human genes have two or more splicing variants33, in which the insertion- or deletion-type splicing represented by neuroligins and neurexins is predominant33. Because the minimal transcript is functional in most splicing cases, most of the inserts or deletions should be not essential to the structural integrity of, and should extend from, the core scaffold, as observed in neuroligins and neurexins. Therefore, regulating protein-protein recognition by modulating the strength of the interactions, especially salt bridges, at the edges of protein-protein interfaces, as represented by NL1 site B and neurexin SS 4, may be a general mechanism for a large pool of alternative splicing–regulated biological events.

Our NL1–NX1beta structure reveals how minor sequence variations among neuroligins can determine their different NX1beta-binding capacities. In particular, NL2, because its Gln475 substitutes for NL1 Gly500, is sterically incompatible with the neuroligin-binding surface of neurexins. This suggests that neurexins are unlikely to serve as NL2 receptors and favors the opinion that NL1 and NL2 have different functional roles2, 3, 34. Our structure also indicates that most of the point mutations found in autism may be structurally disruptive, probably compromising the synthesis of functional neuroligins. Consistent with our analysis, the NL3 R451C mutant has been demonstrated to be defective in transport to the cell surface8, 9, 35. Intriguingly, a recent study of NL3 mutant mice suggested that NL3 R451C is a gain-of-function mutation36. The exact consequences of this mutation should be further addressed both structurally and functionally.

Top

Methods

Constructs and mutagenesis.

The coding sequence of the NL1 extracellular CLD domain (residues 26–638) was cloned adjacent to an N-terminal 7-His-tag in pAcGP67A (PharMingen). The coding sequence for the NX1beta LNS domain (residues 82–292), devoid of splice insert (residues 201–230), was cloned adjacent to a C-terminal 7-His-tag, also in pAcGP67A. A cleavable glutathione S-transferase (GST) fusion NX1beta construct with no His-tag was prepared using pET-49 (Novagen). We used overlap extension PCR, based on pAcGP67A-NL1 and pET-49-NX1beta constructs, to generate mutation in NL1 and NX1beta, respectively. We verified all constructs and mutations by DNA sequencing.

Protein preparation.

We prepared His-tagged NL1, its mutants and NX1beta from baculovirus-infected insect cells. Recombinant baculovirus was produced by transecting sf9 cells with the pAcGP67A constructs together with linearized baculovirus DNA (BacVector-3000, EMD). After amplification, we used the viruses to infect 1–6 liters of Hi5 cells at a density of 1.8 times 106 cells ml- 1 in HyQ SFX medium (HyClone). Cell cultures were grown for 66 h and were then collected by centrifugation. The proteins in the supernatant were captured by Ni-NTA resin and eluted with 200 mM imidazole pH 7.5. They were further purified with size exclusion columns equilibrated with HBS buffer (10 mM HEPES, 150 mM NaCl, pH 7.5).

Non-His-tagged NX1beta and its mutants were expressed as intracellular soluble GST fusion proteins from rosetta-gami2 Escherichia coli cells (Novagen) induced at 25 °C. We purified proteins with a glutathione-agarose column and gel filtration, and cleaved them with HRV-3C protease overnight. The cleaved NX1beta proteins were passed through a second glutathione-agarose column to separate uncleaved proteins, and further purified by a second gel filtration column.

Crystallization and X-ray data collection.

NL1 and NX1beta proteins were concentrated to 10 mg ml- 1 in HBS with 5 mM CaCl2 and combined at a 3:1 ratio (v/v) for crystallization. We obtained crystals through sitting-drop vapor diffusion. The drops contained equal volumes of the protein and the reservoir solution (1.0 M sodium citrate, 0.1 M sodium cacodylate, pH 6.5, 0.2 M NaCl, 10 mM CaCl2). X-ray diffraction was measured at 0.9797 Å wavelength at beamlines 22-BM-C and 21-ID-D at the Advanced Photon Source, Argonne, Illinois, USA. Crystals were cryoprotected with 10% (v/v) glycerol in the mother liquor before flash-cooling to 100 K. The data were indexed, integrated and scaled with HKL2000 (ref. 37). To prevent Ca2+ from being chelated by citrate, we used a separate cryoprotecting solution with acetate replacing citrate and with a higher Ca2+ concentration (3 M sodium acetate, 0.1 M sodium cacodylate, pH 6.5, 0.1 M CaCl2, 10% (v/v) glycerol) to gradually adapt the crystals before flash-cooling for X-ray diffraction.

Structure determination and refinement.

We determined the structure using the molecular replacement program PHASER38, with mouse AChE (PDB 1N5M) and free NX1beta (PDB 1C4R) as search models. We rebuilt the model of the complex using O (ref. 39) and refined it using CNS40. In the final model, each NL1 contained two N-linked glycans (Asn109 and Asn547) with well-defined electron density; a third potential CLD glycosylation site, Asn343, was mutated to glutamine to facilitate crystallization. In the Ramachandran plot, 85.0%, 14.4%, 0.6% and 0% of the residues fell in favored, allowed, generally allowed and disallowed regions, respectively. The statistics of data collection and refinement are summarized in Table 1.


His-tag pull-down assays.

Small columns loaded with 0.5 ml Ni-NTA agarose beads (bed volume approx0.25 ml) were washed with binding buffer (20 mM HEPES, pH 7.5, 10 mM CaCl2). We then loaded an equal amount of N-terminally His-tagged NL1 proteins (0.2 ml at 0.8 mg ml- 1) onto each column and washed the columns with 2 ml binding buffer. The His-tag-free NX1beta and its mutants, cleaved from GST fusion protein, were buffer-exchanged into the binding buffer with gel filtration, adjusted to equal concentrations (0.5 mg ml- 1) and loaded in equal amounts (0.5 ml) onto the NL1-bound columns. Binding buffer (2 ml) was applied to wash off unbound NX1beta proteins. The retained NX1beta proteins, together with NL1 proteins, were then eluted off the Ni-NTA columns with 0.5 ml 0.2 M imidazole, pH 7.5 in HBS, and analyzed with SDS-PAGE.

Isothermal titration calorimetry.

We performed calorimetric titrations on a VP-ITC calorimeter (MicroCal) at 30 °C and processed the data with MicroCal Origin 5.0 software. The protein concentration was determined by the bicinchoninic acid assay with BSA as the standard (Pierce). For measuring NL1-NX1beta interactions, the proteins purified from insect cells were buffer-exchanged into an identical lot of binding buffer (20 mM HEPES, pH 7.5, 10 mM CaCl2) using gel filtration to control buffer heat dilution effects. Before each titration, protein samples were degassed for 10 min. We then added the NX1beta proteins to NL1 over the course of many injections until the NL1 was fully saturated. For measuring binding interactions between NX1beta and Ca2+, we added native NX1beta to a chelating solution with a final concentration of 50 mM EDTA, pH 8.0, to remove residual Ca2+ potentially derived from cell culture. The protein was then buffer-exchanged to 20 mM HEPES, pH 7.5, using gel filtration. We prepared a CaCl2 solution by dissolving CaCl2 directly into the same 20 mM HEPES buffer and then added it to NX1beta during the course of titration.

Accession codes.

Protein Data Bank: Coordinates and structural factors have been deposited with accession code 3B3Q.

Note: Supplementary information is available on the Nature Structural & Molecular Biology website.

Author Contributions

X.C., H.L., A.H.R.S. and P.J.F. carried out experiments; X.H. supervised the research; X.C. and X.H. wrote the article.



Top

Acknowledgments

We thank E.M. Silinsky for critically reading the manuscript and K.C. Garcia for encouragement. X.H. is supported by the Brain Tumor Society and US National Institutes of Health grant 1R01GM078055. The Structural Biology Facility is supported by the R.H. Lurie Comprehensive Cancer Center of Northwestern University. We thank the Southeast Regional Collaborative Access Team (SER-CAT) and Life Sciences Collaborative Access Team (LS-CAT) at the Advanced Photon Source, Argonne National Laboratory, for assistance in data collection.

Received 5 September 2007; Accepted 16 November 2007; Published online 16 December 2007.

Top

References

  1. Craig, A.M., Graf, E.R. & Linhoff, M.W. How to build a central synapse: clues from cell culture. Trends Neurosci. 29, 8–20 (2006). | Article | PubMed | ChemPort |
  2. Chih, B., Engelman, H. & Scheiffele, P. Control of excitatory and inhibitory synapse formation by neuroligins. Science 307, 1324–1328 (2005). | Article | PubMed | ChemPort |
  3. Chubykin, A.A. et al. Activity-dependent validation of excitatory versus inhibitory synapses by neuroligin-1 versus neuroligin-2. Neuron 54, 919–931 (2007). | Article | PubMed | ChemPort |
  4. Graf, E.R., Zhang, X., Jin, S.X., Linhoff, M.W. & Craig, A.M. Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. Cell 119, 1013–1026 (2004). | Article | PubMed | ISI | ChemPort |
  5. Scheiffele, P., Fan, J., Choih, J., Fetter, R. & Serafini, T. Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. Cell 101, 657–669 (2000). | Article | PubMed | ISI | ChemPort |
  6. Song, J.Y., Ichtchenko, K., Sudhof, T.C. & Brose, N. Neuroligin 1 is a postsynaptic cell-adhesion molecule of excitatory synapses. Proc. Natl. Acad. Sci. USA 96, 1100–1105 (1999). | Article | PubMed | ChemPort |
  7. Varoqueaux, F. et al. Neuroligins determine synapse maturation and function. Neuron 51, 741–754 (2006). | Article | PubMed | ISI | ChemPort |
  8. Chih, B., Afridi, S.K., Clark, L. & Scheiffele, P. Disorder-associated mutations lead to functional inactivation of neuroligins. Hum. Mol. Genet. 13, 1471–1477 (2004). | Article | PubMed | ISI | ChemPort |
  9. Comoletti, D. et al. The Arg451Cys-neuroligin-3 mutation associated with autism reveals a defect in protein processing. J. Neurosci. 24, 4889–4893 (2004). | Article | PubMed | ISI | ChemPort |
  10. Feng, J. et al. High frequency of neurexin 1beta signal peptide structural variants in patients with autism. Neurosci. Lett. 409, 10–13 (2006). | Article | PubMed | ChemPort |
  11. Jamain, S. et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet. 34, 27–29 (2003). | Article | PubMed | ISI | ChemPort |
  12. Laumonnier, F. et al. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am. J. Hum. Genet. 74, 552–557 (2004). | Article | PubMed | ISI | ChemPort |
  13. Szatmari, P. et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat. Genet. 39, 319–328 (2007). | Article | PubMed | ISI | ChemPort |
  14. Talebizadeh, Z. et al. Novel splice isoforms for NLGN3 and NLGN4 with possible implications in autism. J. Med. Genet. 43, e21 (2006). | Article | PubMed | ChemPort |
  15. Yan, J. et al. Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients. Mol. Psychiatry 10, 329–332 (2005). | Article | PubMed | ISI | ChemPort |
  16. Lise, M.F. & El-Husseini, A. The neuroligin and neurexin families: from structure to function at the synapse. Cell. Mol. Life Sci. 63, 1833–1849 (2006). | Article | PubMed | ISI | ChemPort |
  17. Missler, M., Hammer, R.E. & Sudhof, T.C. Neurexophilin binding to alpha-neurexins. A single LNS domain functions as an independently folding ligand-binding unit. J. Biol. Chem. 273, 34716–34723 (1998). | Article | PubMed | ISI | ChemPort |
  18. Rudenko, G., Nguyen, T., Chelliah, Y., Sudhof, T.C. & Deisenhofer, J. The structure of the ligand-binding domain of neurexin Ibeta: regulation of LNS domain function by alternative splicing. Cell 99, 93–101 (1999). | Article | PubMed | ISI | ChemPort |
  19. Comoletti, D. et al. Characterization of the interaction of a recombinant soluble neuroligin-1 with neurexin-1beta. J. Biol. Chem. 278, 50497–50505 (2003). | Article | PubMed | ChemPort |
  20. Comoletti, D. et al. Gene selection, alternative splicing, and post-translational processing regulate neuroligin selectivity for beta-neurexins. Biochemistry 45, 12816–12827 (2006). | Article | PubMed | ChemPort |
  21. Comoletti, D. et al. Synaptic arrangement of the neuroligin/beta-neurexin complex revealed by X-ray and neutron scattering. Structure 15, 693–705 (2007). | Article | PubMed | ChemPort |
  22. Nguyen, T. & Sudhof, T.C. Binding properties of neuroligin 1 and neurexin 1beta reveal function as heterophilic cell adhesion molecules. J. Biol. Chem. 272, 26032–26039 (1997). | Article | PubMed | ISI | ChemPort |
  23. Boucard, A.A., Chubykin, A.A., Comoletti, D., Taylor, P. & Sudhof, T.C. A splice code for trans-synaptic cell adhesion mediated by binding of neuroligin 1 to alpha- and beta-neurexins. Neuron 48, 229–236 (2005). | Article | PubMed | ISI | ChemPort |
  24. Chih, B., Gollan, L. & Scheiffele, P. Alternative splicing controls selective trans-synaptic interactions of the neuroligin–neurexin complex. Neuron 51, 171–178 (2006). | Article | PubMed | ISI | ChemPort |
  25. Graf, E.R., Kang, Y., Hauner, A.M. & Craig, A.M. Structure function and splice site analysis of the synaptogenic activity of the neurexin-1beta LNS domain. J. Neurosci. 26, 4256–4265 (2006). | Article | PubMed | ISI | ChemPort |
  26. Ichtchenko, K. et al. Neuroligin 1: a splice site-specific ligand for beta-neurexins. Cell 81, 435–443 (1995). | Article | PubMed | ISI | ChemPort |
  27. Ichtchenko, K., Nguyen, T. & Sudhof, T.C. Structures, alternative splicing, and neurexin binding of multiple neuroligins. J. Biol. Chem. 271, 2676–2682 (1996). | Article | PubMed | ISI | ChemPort |
  28. Bourne, Y., Taylor, P. & Marchot, P. Acetylcholinesterase inhibition by fasciculin: crystal structure of the complex. Cell 83, 503–512 (1995). | Article | PubMed | ISI | ChemPort |
  29. Sheckler, L.R., Henry, L., Sugita, S., Sudhof, T.C. & Rudenko, G. Crystal structure of the second LNS/LG domain from neurexin 1alpha: Ca2. binding and the effects of alternative splicing. J. Biol. Chem. 281, 22896–22905 (2006). | Article | PubMed | ChemPort |
  30. Lo Conte, L., Chothia, C. & Janin, J. The atomic structure of protein-protein recognition sites. J. Mol. Biol. 285, 2177–2198 (1999). | Article | PubMed | ISI | ChemPort |
  31. Dean, C. & Dresbach, T. Neuroligins and neurexins: linking cell adhesion, synapse formation and cognitive function. Trends Neurosci. 29, 21–29 (2006). | Article | PubMed | ISI | ChemPort |
  32. Meijers, R. et al. Structural basis of Dscam isoform specificity. Nature 449, 487–491 (2007). | Article | PubMed | ChemPort |
  33. Kim, E., Magen, A. & Ast, G. Different levels of alternative splicing among eukaryotes. Nucleic Acids Res. 35, 125–131 (2007). | Article | PubMed | ChemPort |
  34. Prange, O., Wong, T.P., Gerrow, K., Wang, Y.T. & El-Husseini, A. A balance between excitatory and inhibitory synapses is controlled by PSD-95 and neuroligin. Proc. Natl. Acad. Sci. USA 101, 13915–13920 (2004). | Article | PubMed | ChemPort |
  35. Chubykin, A.A. et al. Dissection of synapse induction by neuroligins: effect of a neuroligin mutation associated with autism. J. Biol. Chem. 280, 22365–22374 (2005). | Article | PubMed | ChemPort |
  36. Tabuchi, K. et al. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 318, 71–76 (2007). | Article | PubMed | ChemPort |
  37. Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307–326 (1997). | ISI | ChemPort |